ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

In Brief Election Results Won’t Hurt Cancer Program, May Help; Coper To Stay If Carter Wants Him

November 12, 1976

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

Radiation Exposure Mostly Natural, NCRP Report Says

November 27, 1987

ANG1005 Demonstrates Activity In Patients with Brain Metastases

November 29, 2013

In Brief: New Greg For Surgery Research Approved; Only 30 Bioassay Program Reports Still In Backlog

April 21, 1978